The Human Proteoform Project: Defining the human proteome
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 9 of the 30 sources its claims cite were checked for support.
Abstract
An ambitious initiative is proposed to generate a definitive reference set of human proteoforms.
Overview
CoChat Summary
## TL;DR
The paper is a roadmap/proposal for the Human Proteoform Project, arguing that understanding biology and disease requires a comprehensive reference atlas of human proteoforms, not just genome sequence. It proposes a two-pronged strategy: deep proteoform analysis in medically relevant systems and large-scale technology development for proteoform discovery and characterization.
## Key findings
- The authors argue that the human proteome should be defined as the set of all proteoforms expressed by an organism, because proteins from a single gene can vary through genetic variation, alternative splicing, and PTMs.
- They propose an atlas-building strategy centered on two paths: global studies of detectable proteoforms and targeted studies of proteoform families from each human gene.
- The paper gives explicit scale estimates for the project: assuming 5,000 cell types and a depth of 1 million proteoforms in each, the Human Proteoform Atlas would involve about 5 billion measurements of redundant proteoforms; combined with the gene-based approach, it anticipates about 50 million unique (nonredundant) proteoforms with defined quality metrics.
- It notes that current bottom-up proteomics remains limited: the aggregated NCI-60 dataset covers only 12% of the whole encoded proteome, only about 5% of genes had >50% sequence coverage of their protein-coding regions, and detection of alternative splice forms remains very limited (<0.1% of putative novel splice junctions in cancer xenografts).
## Methods
- Not an empirical study; this is a perspective/proposal article laying out a conceptual framework and roadmap for the Human Proteoform Project.
- The proposed design combines cell-based proteoform discovery across defined human cell types with a gene-based targeted approach using affinity reagents to enrich proteoform families.
- The main analysis is argumentative and strategic: it synthesizes existing proteomics limitations, compares top-down and bottom-up approaches, and uses rough scale estimates to motivate technology development and atlas construction.
## Limitations
- The paper states that today’s ability to comprehensively identify proteoforms in complex systems is limited, and that top-down proteomics is powerful but still limited in depth and throughput.
- It explicitly says the project will necessarily focus on capturing the dominant functional proteoform population rather than rare occurrences.
- Evident from the text: the paper does not present new experimental data or validate the proposed atlas; its estimates and goals are forward-looking projections rather than results.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
6 Valid · 2 Not valid · 13 Not checked · 14 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“At present, the dominant “bottom-up” paradigm of mass spectrometry (MS)–based proteomics sacrifices information about proteoforms by cleaving proteins into peptides; this is done for a pragmatic reason—it works, as the resultant peptides are generally much easier to identify than their parent intact proteoforms ( 8 , 9 ).”
What the sources say
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genetic variation, alternative splicing, and posttranslational modification (PTM) work together to create a rich variety of different proteoforms arising from our genes ( Fig. 1 ) ( 3 ).”
What the sources say
- Supportedcites [3] source
In “To the Editor,” the paper says protein complexity arises from allelic variation, alternative RNA splicing, and post-translational modifications. It then defines proteoforms as the different molecular forms of a single gene’s protein product, including forms produced by all three mechanisms (Fig. 1). (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Proteins are the central intermediaries between genotype and phenotype ( 2 – 4 ).”
What the sources say
- Not checked yetcites [2] source
- Supportedcites [3] source
In “To the Editor” (page not specified), the paper links genetic and RNA variation to distinct protein molecules, then says those molecules modulate a wide variety of biological processes. That supports the broad description of proteins as intermediaries between genotype and phenotype. (LLM, conf=0.85)
- Supportedcites [4] source
The Abstract (p. 3) describes proteins as deeply involved in the major processes of life and occupying the space between human genetics and diverse phenotypes. This supports the citing sentence’s paraphrase. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“While today’s mass spectrometric platforms are pushing toward detection limits of ~25 copies per cell ( 7 ),”
What the sources say
- Partly supportedcites [7] sourceExperimental — accuracy not yet measured
Our copy does address mass-spectrometric detection sensitivity at the per-cell copy-number level, but the only threshold it gives is a project requirement, not a current capability: 'A cell-based Human Proteome Project places a premium on defining and isolating specific cell types prior to analysis with 100 % sequence coverage for proteoforms detected at a copy number of 10 and above' (Discussion > Defining the Proteome of Specific Cell Types). Nowhere in the paper is a '~25 copies per cell' detection limit stated, nor is any figure attributed to 'today's mass spectrometric platforms' current push; the nearby numbers (~10,000 expressed proteins detectable from a single human cell type, ~250,000 detectable proteoforms per cell type, <20 % sequence-space coverage of mainstream technologies) concern protein/proteoform counts and coverage, not copies-per-cell limits. So the direction of the claim (MS sensitivity approaching low copy numbers per cell) is in the source, but the specific ~25 value and its framing as present-day capability are not supported. (LLM, conf=0.62)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A statement the paper makes itself — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The depth of proteoform analysis obtained depends on the detection sensitivity of the technology used:”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
5 more claims
Create a free account to see all 35 claims and to verify the 21 references still open.
- Probably not a substantial claim. 17
- It may state two separate claims as one. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A full characterization of protein variability also remains a major technical challenge, since the approximately 20,300 human coding genes can produce hundreds of thousands of protein variants through alternative splicing and posttranslational modification (PTM) (129, 130).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [129]
Experimental — accuracy not yet measured
Citations
Cites
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
A subcellular map of the human proteome
Thul, P. J., Åkesson, L., Wiking, M., Mahdessian, D., Geladaki, A., Ait Blal, H., Alm, T., Asplund, A., Björk, L., Breckels, L. M., et al. (2017) · Science · doi:10.1126/science.aal3321 · Cited by 2,813 · cited 2×
“Prior initiatives such as those describing first drafts of the human proteome in 2014 (33, 34) and ongoing work under the aegis of the Human Protein Atlas and the Human Proteome Project (35) have accomplished a great deal over the past several years, and the Human Proteome Organization has called for the community to…”
MethodEcosystem as Structure: An Actionable Construct for Strategy
Adner, R. (2017) · Journal of Management · doi:10.1177/0149206316678451 · Cited by 2,600
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334 · cited 1×
“NEW TECHNOLOGIES At present, the dominant “bottom-up” paradigm of mass spectrometry (MS)–based proteomics sacrifices information about proteoforms by cleaving proteins into peptides; this is done for a pragmatic reason—it works, as the resultant peptides are generally much easier to identify than their parent intact p…”
BackgroundRegev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C., Birney, E., Bodenmiller, B., Campbell, P., Carninci, P., Clatworthy, M., et al. (2017) · eLife · doi:10.7554/elife.27041 · Cited by 2,232
A draft map of the human proteome
Kim, M.-S., Pinto, S. M., Getnet, D., Nirujogi, R. S., Manda, S. S., Chaerkady, R., Madugundu, A. K., Kelkar, D. S., Isserlin, R., Jain, S., et al. (2014) · Nature · doi:10.1038/nature13302 · Cited by 2,198
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820 · cited 1×
“Prior initiatives such as those describing first drafts of the human proteome in 2014 (33, 34) and ongoing work under the aegis of the Human Protein Atlas and the Human Proteome Project (35) have accomplished a great deal over the past several years, and the Human Proteome Organization has called for the community to…”
MethodA vision for the future of genomics research
Collins, F. S., Green, E. D., Guttmacher, A. E., Guyer, M. S., & on behalf of the US National Human Genome Research Institute (2003) · Nature · doi:10.1038/nature01626 · Cited by 1,752 · cited 3×
“Proteins are primary effectors of function in biology, and thus, complete knowledge of their structure and behavior is fundamental to deciphering function in basic and translational research (2).”
BackgroundMethodProteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Proteoform: a single term describing protein complexity
The Consortium for Top Down Proteomics, Smith, L. M., & Kelleher, N. L. (2013) · Nature Methods · doi:10.1038/nmeth.2369 · Cited by 1,528
Self-citation
Cited by
Items 101–200 of 240
Lieu, L. B., Hinkle, J. D., Syka, J. E. P., & Fornelli, L. (2024) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.4c00391 · Cited by 8
Dowling, P., Trollet, C., Négroni, E., Swandulla, D., & Ohlendieck, K. (2024) · Proteomes · doi:10.3390/proteomes12010004 · Cited by 11
Wang, Q., Fang, F., & Sun, L. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04677-9 · Cited by 8
Puzzle of Proteoform Variety—Where Is a Key?
Naryzhny, S. (2024) · Proteomes · doi:10.3390/proteomes12020015 · Cited by 11
“…species” and is used to designate “all the different molecular forms in which the protein product of a single gene can be found, including changes due to ge-netic variations, alternatively spliced RNA transcripts, and The classical scheme for the generation of proteoforms is shown in Figure 1 [12].”
BackgroundStageTip: a little giant unveiling the potential of mass spectrometry-based proteomics
Kanao, E., & Ishihama, Y. (2025) · Analytical Sciences · doi:10.1007/s44211-025-00749-1 · Cited by 9
Sadeghi, S. A., Li, K., Yue, Y., Nimavard, R. T., Grumelot, S., Saei, A. A., Vali, H., Fang, F., Liu, X., Mahmoudi, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74306-3 · Cited by 11
Chen, C., Wen, M., & Jin, Y. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00180 · Cited by 7
In-depth structural proteomics integrating mass spectrometry and polyacrylamide gel electrophoresis
Takemori, N., & Takemori, A. (2023) · Frontiers in Analytical Science · doi:10.3389/frans.2022.1107183 · Cited by 8
“In particular, SDS-PAGE can demonstrate its maximum potential in the large-scale analysis of intact proteoforms by top-down MS, known as top-down proteomics (Smith and Kelleher., 2013; Smith et al., 2021).”
BackgroundMultiplatform High-Definition Ion Mobility Separations of the Largest Epimeric Peptides
Thurman, H. A., Wijegunawardena, G., Berthias, F., Williamson, D. L., Wu, H., Nagy, G., Jensen, O. N., & Shvartsburg, A. A. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c03079 · Cited by 7
Selheim, F., Aasebø, E., Reikvam, H., Bruserud, Ø., & Hernandez-Valladares, M. (2025) · Proteomes · doi:10.3390/proteomes13010011 · Cited by 8
Lázár, J., Antal‐Szalmás, P., Kurucz, I., Ferenczi, A., Józsi, M., Tornyi, I., Muller, M., Fekete, J. T., Lamont, J. V., FitzGerald, P. S., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100580 · Cited by 8
“establishment of the Human Proteoform Project (13).”
BackgroundTriboelectric nanogenerators: Low-cost power supplies for improved electrospray ionization
Vallejo, D. D., Corstvet, J. L., & Fernández, F. M. (2023) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2023.117167 · Cited by 7
High Sensitivity Top-down Proteomics Captures Single Muscle Cell Heterogeneity in Large ProteoformsPreprint
Melby, J. A., Brown, K. A., Gregorich, Z. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.29.521273 · Cited by 7
Self-citationSample preparation and cleanup methods for clinical top-down proteomics
Kamal, A. M., Carfagno, A. K., Nagy, C., & Fornelli, L. (2025) · Expert Review of Proteomics · doi:10.1080/14789450.2025.2539913 · Cited by 7
“…human plasma proteome project (https://www. hupo.org/plasma-proteome-project) and the human proteo-form project (https://proteomics.northwestern.edu/services/ human-proteoform-project/) have been made publicly available and updated with information regarding variation in protein structure [12,13].”
Radical-Initiated Photodissociation at Tryptophan Residues within Intact Proteins in the Gas Phase
He, L., Purcell, A. G., Beran, G. J. O., Zhu, Y., Coronado, K. C., Mann, S. I., Harman, W. H., & Julian, R. R. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c07784 · Cited by 6
Wilson, M. C., Josvai, M. B., Walters, J. K., Lawson, J., Rossler, K. J., Gao, Z., Zhu, Y., Kamp, T. J., Crone, W. C., Eckhardt, L. L., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00505 · Cited by 7
Self-citationProteomic changes in the hippocampus of large mammals after total-body low dose radiation
Iacono, D., Hatch, K., Murphy, E. K., Post, J. D., Cole, R. N., Perl, D. P., & Day, R. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296903 · Cited by 9
Discovery top-down proteomics in symbiotic soybean root nodules
Zhou, M., Fulcher, J. M., Zemaitis, K. J., Degnan, D. J., Liao, Y., Veličković, M., Veličković, D., Bramer, L., Kew, W., Stacey, G. S., et al. (2022) · Frontiers in Analytical Science · doi:10.3389/frans.2022.1012707 · Cited by 8
“the Human Proteoform Atlas project.(Hollas et al., 2021; Smith et al., 2021; Melani et al., 2022) The limitations of intact protein sample complexity, low sensitivity, and”
BackgroundSelf-citationIsoForma: An R Package for Quantifying and Visualizing Positional Isomers in Top-Down LC-MS/MS Data
Degnan, D. J., Lewis, L. A., Bramer, L., McCue, L. A., Pesavento, J. J., Zhou, M., & Pena, A. B. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00681 · Cited by 6
Guzman, N. A., & Guzman, A. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4020020 · Cited by 10
“This area of research encompasses a broad range of technologies aimed at determining the identity and quantity of expressed proteins in cells, their three-dimensional structure, and interacting molecules [67–69].”
BackgroundProteoforms and Proteoform Families: Past, Present, and Future
Smith, L. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2325-1_1 · Cited by 6
Self-citationHornburg, D., Ferdosi, S., Hasan, M., Tangeysh, B., Brown, T. R., Wang, T., Elgierari, E. M., Zhao, X., Alavi, A., Chu, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.08.475439 · Cited by 6
Multifaceted Landscape of Omics Data
Mudadla, T., Sharma, G., Mishra, A., & Gola, S. (2024) · Bio-Algorithms and Med-Systems · doi:10.5604/01.3001.0054.8093 · Cited by 6
Complexoform-restricted covalent TRMT112 ligands that allosterically agonize METTL5
Goetzke, F. W., Bernard, S. M., Ju, C., Pollock, J., DeMeester, K. E., Gross, J., Simon, G. M., He, C., Melillo, B. N., & Cravatt, B. F. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02099-5 · Cited by 10
“The resulting products ( 3 , 4 ) are then subjected to a diastereoselective and regioselective rhodium-catalyzed hydroboration–oxidation sequence ( 5 , 6 ) 28 with an optional Mitsunobu stereoinversion of the secondary alcohol to access the alternative diastereomers ( 7 , 8 ) (Extended Data Fig.”
Mass Spectrometry-based Proteomics of Eukaryotes
Geddes‐McAlister, J., Rizakos, T., & Muselius, B. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781837670338-00215 · Cited by 5
Li, K., Huo, Q., Li, B., & Yokota, H. (2023) · Proteomes · doi:10.3390/proteomes11010005 · Cited by 5
Zhang, Y., Minami, R., Tatsuno, R., Gao, W., Ueno, M., Yamada, A., Yoshida, A., Sedanza, M. G., Arima, K., Takatani, T., et al. (2023) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbad095 · Cited by 5
TopDownApp: An open and modular platform for analysis and visualisation of top‐down proteomics data
Walzer, M., Jeong, K., Tabb, D. L., & Vizcaíno, J. A. (2023) · PROTEOMICS · doi:10.1002/pmic.202200403 · Cited by 5
“Furthermore, in our view, the availability of open source analysis platforms will be essential to the success of the envisioned Human Proteoform Project [28].”
BackgroundLarge-scale single-molecule analysis of tau proteoformsPreprint
Joly, J. P., Budamagunta, V., Zhang, Z., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.26.660445 · Cited by 5
Transcription factor prediction using protein 3D secondary structures
(2024) · doi:10.1093/bioinformatics/btae762 · Cited by 4
“Because biomolecular processes, e.g. alternative splicing and post-translational modifications, create a variety of protein forms (Smith et al. 2021), experimentally testing each protein form regarding its ability to act as a TF is not feasible.”
Liu, X., Yi, L., Lin, Z., Chen, S., Wang, S., Sheng, Y., Lebrilla, C. B., Garcia, B. A., & Xie, Y. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2422936122 · Cited by 4
Gao, Z., Rossler, K. J., Rogers, H. T., Gregorich, Z. R., Aballo, T. J., Chapman, E. A., Price, S. J., Hermsen, J. L., de Lange, W. J., Zhu, Y., et al. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.012899 · Cited by 7
Self-citationSingle-molecule peptide sequencing through reverse translation of peptides into DNA
Zheng, L., Sun, Y., Hein, L. A., Eisenstein, M. S., & Soh, H. T. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03061-z · Cited by 9
Ackermann, B. L. (2024) · Bioanalysis · doi:10.1080/17576180.2024.2415763 · Cited by 4
Zemaitis, K. J., & Paša‐Tolić, L. (2024) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2025.151583 · Cited by 5
Self-citationSelective Comprehensive Online NanoLCxCZE-MS Platform for Top-Down Proteoform Analysis
Waldmann, T., Kaulich, P. T., Stolz, A., Tholey, A., & Neusüß, C. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03469 · Cited by 4
Brown, S. L., Zenaidee, M. A., Loo, J. A., Loo, R. R. O., & Donald, W. A. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01654 · Cited by 6
Self-citation-Omics Technologies and Big Data
Poetsch, A., & Li, Y. (2023) · Translational bioinformatics · doi:10.1007/978-981-19-8210-1_3 · Cited by 6
Quantitative Aspects of the Human Cell Proteome
Naryzhny, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108524 · Cited by 5
“Identification and quantification of the proteome’s components in different human tissues provide a valuable resource for understanding the multiple processes performed [1].”
BackgroundTornyi, I., Lázár, J., Pettkó‐Szandtner, A., Hunyadi‐Gulyás, É., & Takács, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814359 · Cited by 4
“Among others, this is well reflected by the approaches of the Protein Atlas [4,5] or the efforts of the Proteoform Consortium [6,7].”
MethodJin, L., Wang, F., Wang, X., Harvey, B. P., Bi, Y., Hu, C., Cui, B., Darcy, A. T., Maull, J. W., Phillips, B. R., et al. (2023) · Proteomes · doi:10.3390/proteomes11040032 · Cited by 8
Proteomic Changes in the Hippocampus after Repeated Explosive-Driven Blasts
Iacono, D., Hatch, K., Murphy, E. K., Cole, R. N., Post, J. D., Leonessa, F., & Perl, D. P. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00628 · Cited by 4
Bosma, M., & Cobbaert, C. M. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0152 · Cited by 6
Post‐Translational Modifications in Cilia and Ciliopathies
Ran, J., & Zhou, J. (2025) · Advanced Science · doi:10.1002/advs.202416562 · Cited by 8
Shahinuzzaman, A. D. A., Kamal, A. H. M., Chakrabarty, J. K., Rahman, A., & Chowdhury, S. M. (2022) · Proteomes · doi:10.3390/proteomes10030031 · Cited by 4
Cobbaert, C. M., Deprez, L., & Ruhaak, L. R. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-24575-6_20 · Cited by 5
The impact of genetically controlled splicing on exon inclusion and protein structure
Einson, J. E., Minaeva, M., Rafi, F., & Lappalainen, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291960 · Cited by 4
Proteoform‐Selective Imaging of Tissues Using Mass Spectrometry**
Yang, M., Hu, H., Su, P., Thomas, P. M., Camarillo, J. M., Greer, J. B., Early, B. P., Fellers, R. T., Kelleher, N. L., & Laskin, J. (2022) · Angewandte Chemie · doi:10.1002/ange.202200721 · Cited by 6
Self-citationAntithrombin: Deficiency, Diversity, and the Future of Diagnostics
Kruijt, M., Cobbaert, C. M., & Ruhaak, L. R. (2025) · Mass Spectrometry Reviews · doi:10.1002/mas.21929 · Cited by 4
Iona, A., Wang, B., Clarke, J., Chan, K., Kakkoura, M., Clarke, C., Wright, N., Yao, P., Mazidi, M., Im, P. K., et al. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01311-z · Cited by 4
Wilson, M. C., Gao, Z., Lopez, J. R., Zhu, Y., Olszewski, S. S., Konopka, A. R., Diffee, G. M., & Ge, Y. (2026) · Journal of Mass Spectrometry · doi:10.1002/jms.70040 · Cited by 3
Self-citationMetaproteomics of human microbiota: Progress and key challenges for precision medicine
Feng, Y., Liu, D., Chen, Y., Zhang, W., & He, Y. (2025) · Process Biochemistry · doi:10.1016/j.procbio.2025.05.013 · Cited by 3
Methionine Oxidation Footprinting in Intact Proteins (MOFIP) Using Top‐Down Proteomics
Sunny, A. T., Cupp‐Sutton, K. A., Zhao, Z., Chowdhury, T., Guo, Y., & Wu, S. (2025) · PROTEOMICS · doi:10.1002/pmic.70063 · Cited by 4
Comparative Analysis of Proteoform Clean‐Up Methods for In‐Depth Top‐Down Proteomics
Williams, A. A., Firenza, K. N., Carfagno, A. K., Kline, J. T., & Fornelli, L. (2025) · PROTEOMICS · doi:10.1002/pmic.70067 · Cited by 4
“These protein forms, or proteoforms [7], encompass all aspects of variation in expressed gene products; therefore, their analysis may more accurately model differences in disease phenotypes compared to the consideration of generic protein families [8].”
Nevárez-Ramírez, A. J., Guzmán-Ortiz, A. L., Cortés‐Reynosa, P., Perez‐Salazar, E., Jaimes‐Ortega, G. A., Valle‐Rios, R., Marín‐Hernández, Á., Rodríguez‐Zavala, J. S., Ruíz-May, E., Castrejón-Flores, J. L., et al. (2023) · Proteomes · doi:10.3390/proteomes11020015 · Cited by 3
Parsing 20 Years of Public Data by AI Maps Trends in Proteomics and Forecasts Technology
Green, J. J., Grimm, C., Fristo, A., Byrum, J., & Kelleher, N. L. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00430 · Cited by 3
Self-citationProteomics and Its Applications in Cancers 2.0
Naryzhny, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084447 · Cited by 3
“These proteoforms can arise due to alternative splicing, PTMs, processing, and degradation [15,16].”
BackgroundFLASHApp: Interactive Data Analysis and Visualization for Top‐Down Proteomics
Müller, T. D., Kim, J., Almaguer, A., Feroz, A., Kim, J., Walter, A., Jung, W., Kohlbacher, O., & Jeong, K. (2025) · PROTEOMICS · doi:10.1002/pmic.70042 · Cited by 5
Deep thermal proteome profiling for detection of proteoforms and drug sensitivity biomarkersPreprint
Kurzawa, N., Stahl, M. M. S., Leo, I. R., Kunold, E., Becher, I., Audrey, A., Mermelekas, G., Huber, W. K., Mateus, A., Savitski, M. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.10.495491 · Cited by 3
Peptide sequencing via reverse translation of peptides into DNAPreprint
Zheng, L., Sun, Y., Eisenstein, M. S., & Soh, H. T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.31.596913 · Cited by 3
Dens, C., Yeung, D., Krokhin, O. V., Laukens, K., & Bittremieux, W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.18.629045 · Cited by 2
Detecting Amino Acid Variants Using Next-Generation Protein Sequencing (NGPS)Preprint
Chinnaraj, M., Lin, J., Blacklock, K. M., Hermes, E., Meyer, M., Pike, D. H., Vieceli, J., & Chorny, I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.17.629036 · Cited by 3
Spatial distribution of the proteome in the human body and in cancers
Yue, L., Jiang, W., Li, S., Luo, M., Fan, N., Zhan, X., Sun, R., Cheng, H., Xue, Z., Liu, T., et al. (2026) · Nature · doi:10.1038/s41586-026-10660-y · Cited by 10
Mass spectrometry-based absolute quantitative proteomics of drug-metabolizing enzymes in human liver
McCalla, Z., & Wang, X. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108929 · Cited by 2
Proteoform Mapping Calls for a Combined Effort From Bottom‐Up and Top‐Down Proteomics
van der Burgt, Y. V. D. (2025) · Proteomics · doi:10.1002/pmic.70077 · Cited by 2
“…consortium encouraged the field to optimize and innovate TDP strategies aiming for comprehensive proteoform maps and make workflows available for a broader proteomics community, including sample preparation, proteoform separation, MS instrumentation, and computational platforms and software [3, 4].”
Lehe, M. D., Almofeez, R., Jeffery, E. D., & Sheynkman, G. (2026) · Journal of Mass Spectrometry · doi:10.1002/jms.70024 · Cited by 4
Ion Activation Methods for Top‐Down Proteomics
Walker, J. N., & Brodbelt, J. S. (2026) · Mass Spectrometry Reviews · doi:10.1002/mas.70023 · Cited by 5
Beyond Reanalysis: Critical Issues in Data Reuse for Solid Tumor Proteomics
Franzetti, F., Giugni, N., Airoldi, M., Bondi, H., Alberio, T., & Fasano, M. (2026) · Proteomes · doi:10.3390/proteomes14020016 · Cited by 3
Zhu, G., Rodriguez, D. A. A., Gould, N., Ivanov, A. R., Jooß, K., & Sun, L. (2026) · Mass Spectrometry Reviews · doi:10.1002/mas.70028 · Cited by 4
Veenstra, T. D. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-22340-1_1 · Cited by 1
Recent Advances in Top‐Down Proteomics for Single‐Cell Research
Melby, J. A., Su, P., & Gomes, F. P. (2026) · Mass Spectrometry Reviews · doi:10.1002/mas.70031 · Cited by 4
Gabant, G., Stekovic, M., Nemčić, M., et al. (2022) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00215 · Cited by 2
Pavek, J. G., Frey, B. L., Frost, D. C., Gu, T., Li, L., & Smith, L. M. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02473 · Cited by 4
Self-citationCarulla, P., Badia-Villanueva, M., Civit, S., Carrascal, M., Abián, J., Ricart-Jané, D., Llobera, M., Casanovas, A., & López-Tejero, M. D. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1271149 · Cited by 2
Mirshahvaladi, S., Chitranshi, N., Amirkhani, A., Rajput, R., Basavarajappa, D. K., Wall, R. V., Pascovici, D., Godinez, A., Galliciotti, G., Paulo, J. A., et al. (2024) · Proteomes · doi:10.3390/proteomes12010007 · Cited by 2
An integrated landscape of mRNA and protein isoforms
Kedan, A., Zauber, H., Wang, M., Kim, S., Zhu, Q., Fang, L., Lilley, K. S., Chen, W., & Selbach, M. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117898 · Cited by 6
Chan, H., Krichel, B., Bandura, L. J., Chapman, E. A., Rogers, H. T., Fischer, M. S., Roberts, D. S., Gao, Z., Wang, M., Wu, J., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c06950 · Cited by 7
Self-citationSubcellular thermal profiling enables the deep functional exploration of the mitochondrial proteomePreprint
Rivera-Mejías, P., Sueur, C. L., Kurzawa, N., Becher, I., & Savitski, M. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.27.582308 · Cited by 2
“However, it is well documented that from a single gene, a diversity of proteoforms can arise due to alternative splicing events, single amino-acid polymorphism, post-translational modifications, and proteolytic cleavage 30,79 .”
BackgroundMethodMeng, Z., Saei, A. A., Gharibi, H., Zhang, X., Lyu, H., Lundström, S. L., Végvári, Á., Gaetani, M., & Zubarev, R. A. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02051 · Cited by 1
Intact Mass Proteomics Using a Proteoform Atlas
Pavek, J. G., Whitworth, I. T., Nakayama, L., Scalf, M., Frey, B. L., & Smith, L. M. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00838 · Cited by 3
Self-citationDeciphering Proteoform Landscape of Mammary Carcinoma by Top-Down Proteomics
Knott, S. J., Tucholski, T., Josyer, H., Inman, D. R., Friedl, A., Zhu, Y., Ge, Y., & Ponik, S. M. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c01044 · Cited by 2
Self-citationProteomic Analysis of Sputum from Patients with Active Tuberculosis
Marcantonio, E., Woron, A. M., Whelen, A. C., & Prišić, S. (2025) · Proteomes · doi:10.3390/proteomes13030043 · Cited by 1
Rosu, F., Chiba, R., Mallika, A. M., Smyrnakis, A., Greisch, J., Papanastasiou, D. K., & Gabelica, V. (2026) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.5c00386 · Cited by 3
Translation Signature Scores: Data-Driven Approach to Assess Evidence for Active Translation
Menon, D. S., Rackham, O. J. L., & Chothani, S. P. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-5013-4_8 · Cited by 1
ProteoformDB: A Built-In Application to Generate Proteoform Database
Hoàng, T., Hu, Y., & Zhang, H. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00461 · Cited by 1
Luo, Y. R., Chinnaraj, M., Blacklock, K. M., Pike, D. H., Chorny, I., Vieceli, J., & Wong, C. V. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c07226 · Cited by 1
Askarani, M. F., Poulos, W., Dashtaki, M. R., Fang, F., Cibelli, J. B., & Sun, L. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6c00007 · Cited by 1
Chua, E., Zhang, Y., Leong-Seng, L., Yan, X., & Tan, K. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152242 · Cited by 1
Applications of Top‐Down Protein Analysis in Clinical Diagnostics
Mann, M. W., Yeung, P. S.-W., & Luo, Y. R. (2026) · Mass Spectrometry Reviews · doi:10.1002/mas.70030 · Cited by 1
Proteoforms in Disease: Biomedical Applications of Top‐Down Proteomics
Rogers, H. T., Gregorich, Z. R., Gant, M. S., Gao, Z., Chamot‐Rooke, J., & Ge, Y. (2026) · Mass Spectrometry Reviews · doi:10.1002/mas.70042 · Cited by 3
Self-citationLarge-scale single-molecule analysis of tau proteoforms
Joly, J. H., Budamagunta, V., Zhang, Z., Nortman, B., Jouzi, M., Bhatnagar, R., Egertson, J. D., Flaster, M. E., Grothe, R., Guha, S. K., et al. (2026) · Nature Methods · doi:10.1038/s41592-026-03188-6 · Cited by 11
“Finally, there is no comprehensive reference database of human proteoforms, making confident assignment difficult even when high-quality data are available 14 .”
A butterfly effect: From a single nucleotide to altered immunity
Bechtella, L., & Pagel, K. (2023) · Chem · doi:10.1016/j.chempr.2023.02.014 · Cited by 1
Les omiques au service de la myologie
Simon, A. (2023) · médecine/sciences · doi:10.1051/medsci/2023136 · Cited by 1
The need for open and FAIR data in top‐down proteomics
Lermyte, F. (2023) · PROTEOMICS · doi:10.1002/pmic.202300354 · Cited by 2
Revisiting Protein Reversed-Phase Chromatography for Bottom-Up Proteomics
Takagi, S., Suzuki, N., & Ishihama, Y. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00642 · Cited by 1
Liu, Y.-S. (2021) · Preprints.org · doi:10.20944/preprints202111.0333.v1
“In this regard, the recent initiative of The Human Proteoform Project is very timely and extremely important for assembling an atlas with more detailed knowledge by creating a comprehensive proteoform index [32].”
BackgroundAn Introduction to Mass Spectrometry-Based Proteomics
Ball, L. E., Agana, B. A., Comte‐Walters, S., Bethard, J. R., & Burnette, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00143-7 · Cited by 1
Genome-wide single cell annotation of the human protein-coding genesPreprint
Karlsson, M., Álvez, M. B., Shi, M., Méar, L., Schutten, R., Hikmet, F., Digre, A., Katona, B., Vuu, J., Bosić, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.03.502627 · Cited by 3
The impact of genetically controlled splicing on exon inclusion and protein structurePreprint
Einson, J. E., Minaeva, M., Rafi, F., & Lappalainen, T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.05.518915 · Cited by 1
Zenaidee, M. A., Dodgen, T. M., Carroll, L., & Hart‐Smith, G. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-zntk5
Metadata
- Authors
- Smith, L. M., Agar, J. N., Chamot-Rooke, J., Danis, P. O., Ge, Y., Loo, J. A., Paša-Tolić, L., Tsybin, Y. O., Kelleher, N. L., & The Consortium for Top-Down Proteomics
- Affiliations
- University of Wisconsin–Madison (US)
- Northeastern University (US)
- Department of Structural Biology and Chemistry, Institut Pasteur, CNRS, Paris, France.
- Consortium for Top-Down Proteomics, Cambridge, MA, USA.
- University of California, Los Angeles (US)
- Pacific Northwest National Laboratory, Richland, WA, USA.
- Spectroswiss (Switzerland) (CH)
- Northwestern University (US)
- Corresponding author
- Kelleher, Neil L.
- ORCID
- Venue
- Science Advances
- Published
- 2021-11-12
- Volume
- 7
- Issue
- 46
- Pages
- eabk0734-eabk0734
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8589312
- OpenAlex
- W3212853007
- Semantic Scholar
- ec7918066a2371daeda68b271a36d2b5dc582e6d
- Cited by
- 242
- References
- 49
- Citations by year
- 2026: 43 · 2025: 51 · 2024: 51 · 2023: 52 · 2022: 39 · 2021: 6
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Science Advances (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion, cc-by)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?, DEFC0202ER63421, FC02-02ER63421)
- Centre National de la Recherche Scientifique
- National Institutes of Health (DE-FC02-02ER63421, UL1TR001422, HL096971, DE-AC05-76RL01830)
- Office of Science (02ER63421, DEFC0202ER63421, DE‐AC05‐76 RL01830)
- National Heart, Lung, and Blood Institute (R01HL096971)
- National Cancer Institute (UG3CA256959)
- National Institute of General Medical Sciences (P41GM108569, GM117058, R01GM103479, GM125085, R01GM125085, R01GM117058, R35GM126914)
- National Center for Advancing Translational Sciences
- Biological and Environmental Research (DE-AC05-76 RL01830, DE‐FC02‐02ER63421, AC05-76RL01830, 76RL01830)
- Common Fund
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- human proteome, proteoforms, post-translational modification, genetic polymorphism, disease research, proteomics technologies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.